$IRWD insider trading
Over the last 12 months, Ironwood Pharmaceuticals insiders reported no purchases and 11 sales totaling $22.6M across SEC Form 4 filings. 27% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $22.6M 11 events
- Events · 12m
- 11 Form 4 filings, grouped
- Insiders · 12m
- 8 distinct reporters
- 10b5-1 share
- 27% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Silver RonaldPFO & PAO · O | ▼ Sale | 127,890 | $4.52 | $578K | -29% | plan |
| Jun 16, 2026 | McHugh JulieD | ▼ Sale | 21,571 | $3.73 | $80K | -7.9% | plan |
| Mar 17, 2026 | DENNER ALEXANDER JD | ▼ Sale | 6,730,800 | $3.05 | $20.5M | -42.3% | 2 tranches · indirect |
| Feb 24, 2026 | Martini Gregory S.Chief Financial Officer · O | ▼ Sale | 21,944 | $3.73 | $82K | -12% | 2 tranches |
| Feb 24, 2026 | John MinardoChief Legal Officer · O | ▼ Sale | 36,492 | $3.73 | $136K | -9.1% | 2 tranches |
| Feb 24, 2026 | Shetzline MichaelSVP, CMO, Head-Res&Drug · O | ▼ Sale | 32,582 | $3.73 | $122K | -5.9% | 2 tranches |
| Feb 24, 2026 | Gaskins Tammi LChief Commercial Officer · O | ▼ Sale | 21,526 | $3.73 | $80K | -9.1% | 2 tranches |
| Feb 24, 2026 | MCCOURT Thomas AChief Executive Officer · O·D | ▼ Sale | 198,283 | $3.73 | $740K | -11.8% | 2 tranches |
| Feb 24, 2026 | Silver RonaldPrincipal Accounting Officer · O | ▼ Sale | 24,173 | $3.73 | $90K | -8.7% | 2 tranches |
| Jan 5, 2026 | Silver RonaldPrincipal Accounting Officer · O | ▼ Sale | 35,416 | $4.6 | $163K | -11.3% | plan |
| Nov 17, 2025 | Gaskins Tammi LChief Commercial Officer · O | ▼ Sale | 6,016 | $3.32 | $20K | -2.5% | — |
| Aug 11, 2025 | Gaskins Tammi LChief Commercial Officer · O | ▼ Sale | 1,316 | $0.84 | $1K | -0.5% | — |
| Aug 11, 2025 | John MinardoChief Legal Officer · O | ▼ Sale | 7,754 | $0.84 | $7K | -1.9% | — |
| Aug 11, 2025 | Silver RonaldPrincipal Accounting Officer · O | ▼ Sale | 2,846 | $0.84 | $2K | -1% | — |
| Aug 11, 2025 | Martini Gregory S.Chief Financial Officer · O | ▼ Sale | 1,265 | $0.84 | $1K | -0.7% | — |
Every $IRWD filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Ironwood Pharmaceuticals filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IRWD feed.